Agilent Technologies announced it has moved the company’s Cell Analysis Division into its Diagnostics and Genomics Group (DGG) as part of a strategy ...
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and Akron Bio (“Akron&...
As 2024 nears, the healthcare landscape is undergoing unprecedented transformations, particularly with headlines about artificial intelligence (AI) technol...
Thrive Bioscience Inc., a provider of innovative automated live cell imaging instruments and software, debuted its CellAssist Software Release 5.0, a new i...
Charles River Laboratories International, Inc. announced an important milestone in their strategic collaboration to manufacture CASGEVY™ (...
Friedreich’s ataxia is a genetic, debilitating and life-shortening neuromuscular disease1 Milestone highlights Biogen’s growing portfolio in...
Parse Biosciences, a leading provider of easily accessible and scalable solutions for single-cell sequencing, announced today that the company has raised $...
Atomic AI’s ATOM-1 large language model (LLM) demonstrates state-of-the-art accuracy for predicting RNA structure and function Technology can be exp...
OmniAb, Inc. announces the presentation of new scientific data on its OmnidAb™ platform, the industry’s first and only transgenic chicken...
Roivant (Nasdaq: ROIV) announced the completion of the previously announced acquisition by Roche (SIX: RO, ROG; OTCQX: RHHBY) of Telavant, for an upf...
Novozymes and Chr. Hansen announced their future name ‘Novonesis’. The name reflects the beginning of an era of biosolutions where Novonesis wi...
AstraZeneca has entered into a definitive agreement to acquire Icosavax, Inc. (NASDAQ: ICVX), a US-based clinical-stage biopharmaceutical company focused o...
CELLphenomics’ PD3D® tumor model platform will expand Charles River’s portfolio of 3D in vitro testing services Charles Rive...
Bayesian optimization engine that already powers dozens of use cases at Merck now open sourced to foster adoption Close partnership to enable the self-d...
© 2026 Biopharma Boardroom. All Rights Reserved.
